Look Up > Drugs > Anisotropine
Anisotropine
Pronunciation
Generic Available
Synonyms
Pharmacological Index
Use
Pregnancy Risk Factor
Contraindications
Warnings/Precautions
Adverse Reactions
Overdosage/Toxicology
Drug Interactions
Mechanism of Action
Pharmacodynamics/Kinetics
Usual Dosage
Administration
Monitoring Parameters
Mental Health: Effects on Mental Status
Mental Health: Effects on Psychiatric Treatment
Dental Health: Local Anesthetic/Vasoconstrictor Precautions
Dental Health: Effects on Dental Treatment
Patient Information
Nursing Implications
Dosage Forms

Pronunciation
(an iss oh TROE peen)

Generic Available

Yes


Synonyms
Anisotropine Methylbromide

Pharmacological Index

Anticholinergic Agent


Use

Adjunctive treatment of peptic ulcer


Pregnancy Risk Factor

C


Contraindications

Narrow-angle glaucoma, obstructive GI tract or uropathy, severe ulcerative colitis, myasthenia gravis, intestinal atony, hepatic disease, hypersensitivity


Warnings/Precautions

Drug-induced heatstroke can develop in hot or humid climates


Adverse Reactions

>10%:

Cardiovascular: Palpitations

Dermatologic: Dry skin

Gastrointestinal: Constipation, dry throat, xerostomia

Respiratory: Dry nose

Miscellaneous: Diaphoresis (decreased)

1% to 10%:

Endocrine & metabolic: Decreased flow of breast milk

Gastrointestinal: Decreased salivary secretion

<1%: Orthostatic hypotension, confusion, drowsiness, headache, loss of memory, fatigue, rash, bloated feeling, nausea, vomiting, decreased urination, weakness, increased intraocular pain, blurred vision, increased sensitivity to light


Overdosage/Toxicology

Symptoms of overdose include blurred vision, dysphagia, urinary retention, tachycardia, hypertension

Anisotropine toxicity is caused by strong binding of the drug to cholinergic receptors. Anticholinesterase inhibitors reduce acetylcholinesterase, the enzyme that breaks down acetylcholine and thereby allows acetylcholine to accumulate and compete for receptor binding with this offending anticholinergic. For an overdose with severe life-threatening symptoms, physostigmine 1-2 mg (0.5 mg or 0.02 mg/kg for children) S.C. or I.V., slowly may be given to reverse these effects.


Drug Interactions

No data reported


Mechanism of Action

Blocks the action of acetylcholine at parasympathetic sites in smooth muscle, secretory glands, and the CNS; increases cardiac output, dries secretions, antagonizes histamine and serotonin


Pharmacodynamics/Kinetics

Absorption: Poor (~10%) from GI tract

Elimination: Principally in urine as unchanged drug and metabolites


Usual Dosage

Adults: Oral: 50 mg 3 times/day


Administration

Administer 30-60 minutes before meals


Monitoring Parameters

Monitor patient's vital signs and I & O


Mental Health: Effects on Mental Status

Rarely may produce confusion and memory impairment


Mental Health: Effects on Psychiatric Treatment

Anticholinergic effects may be exacerbated by psychotropic with anticholinergic activity (benztropine, TCAs)


Dental Health: Local Anesthetic/Vasoconstrictor Precautions

No information available to require special precautions


Dental Health: Effects on Dental Treatment

>10% of patients experience dry mouth; orthostatic hypotension possible


Patient Information

Dry mouth can be relieved by sugarless gum or hard candy; drink plenty of fluids


Nursing Implications

Monitor vital signs and I & O


Dosage Forms

Tablet, as methylbromide: 50 mg


Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved